Topics

Alexion Pharmaceuticals Inc. Company Profile

13:41 EDT 21st September 2019 | BioPortfolio

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes Soliris® (eculizumab), the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two life-threatening ultra-rare disorders. As the global leader in complement inhibition, Alexion is strengthening and broadening its portfolio of complement inhibitors, including evaluating potential indications for eculizumab in additional severe and ultra-rare disorders. Alexion’s metabolic franchise includes two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare disorders, Strensiq™ (asfotase alfa) to treat patients with hypophosphatasia (HPP) and Kanuma™ (sebelipase alfa) to treat patients with lysosomal acid lipase deficiency (LAL-D). In addition, Alexion is advancing the most robust rare disease pipeline in the biotech industry, with highly innovative product candidates in multiple therapeutic areas. This press release and further information about Alexion can be found at: www.alexion.com.


News Articles [987 Associated News Articles listed on BioPortfolio]

Alexion Inks Two Partnerships: Affibody AB and Zealand Pharma

Alexion Pharmaceuticals announced two big collaboration partnerships today. First, Alexion, headquartered in Boston, and Affibody AB, located in Solna, Sweden, signed a partnership deal to co-develop ...

Alexion's paroxysmal nocturnal hemoglobinuria drug OK'd in EU

Alexion Pharmaceuticals' Ultomiris, or ravulizumab, has been approved by the European Commission as a treatment for adult pat -More- 

Alexion aims for fourth rare disease use for blockbuster Soliris

The FDA has granted a fast review for Alexion Pharmaceuticals’ filing for its Soliris, as a treatment for a rare neurological disease that leads to worsening disability, blindness, paralysis, and po...

Jazz, Alexion and Lundbeck to pay $122m to settle kickback probe

Drugmakers Jazz Pharmaceuticals, Lundbeck and Alexion Pharmaceuticals have agreed to pay a total of $122.6m to settle allegations of paying...Read More... The post Jazz, Alexion and Lundbeck to pay $1...

Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand

Alexion Pharmaceuticals today announced a pair of collaborations totaling potentially more than $1.3 billion—one partnership aimed to co-developing an autoimmune disease treatment, and another aimed...

Expanded use for Alexion's Soliris under FDA priority review status

Alexion Pharmaceuticals' supplemental marketing application for Soliris, or eculizumab, as a treatment for patients with neur -More- 

CHMP recommends Alexion's eculizumab for rare autoimmune disease

Alexion Pharmaceuticals' Soliris, or eculizumab, has received a positive opinion from the European Medicines Agency's Committ -More- 

EU approval for Alexion's PNH drug Ultomiris

The European Commission has approved Alexion Pharmaceuticals' Ultomiris (ravulizumab) for the treatment of some adults with the ultra-rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH).

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Kanuma [alexion pharmaceuticals, inc.]

These highlights do not include all the information needed to use KANUMA safely and effectively. See full prescribing information for KANUMA. KANUMA (sebelipase alfa) injection, for intravenous useIni...

Strensiq [alexion pharmaceuticals, inc.]

These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ® (asfotase alfa) injection, for subcutaneous...

PubMed Articles [137 Associated PubMed Articles listed on BioPortfolio]

Mytilidae as model organisms in the marine ecotoxicology of pharmaceuticals - A review.

Growing production and consumption of pharmaceuticals is a global problem. Due to insufficient data on the concentration and distribution of pharmaceuticals in the marine environment, there are no app...

Occurrence and ranking of pharmaceuticals in the major rivers of China.

Residual pharmaceuticals have received widespread attention worldwide due to their continuous release and potential hazard to the environment. As a result of rapid development and a large population, ...

Occurrence and distribution of pharmaceuticals in raw, finished, and drinking water from seven large river basins in China.

The occurrence of pharmaceuticals in the drinking water is a growing concern in China. In this study, we determined the concentration and distribution of 59 selected pharmaceuticals in raw, finished, ...

U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

National data on morbidity from nonmedical use of pharmaceuticals are limited. This study used nationally representative, public health surveillance data to characterize U.S. emergency department visi...

Simultaneous aqueous chlorination of amine-containing pharmaceuticals.

Amine-containing pharmaceuticals such as acetaminophen, diclofenac, and sulfamethoxazole are the most often detected pharmaceuticals in wastewater and other aquatic environments. Amine-containing phar...

Clinical Trials [244 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1387 Associated Companies listed on BioPortfolio]

Alexion Antibody Technologies, Inc.

Alexion Antibody Technologies, Inc. (AAT) is a wholly owned subsidiary of Alexion Pharmaceuticals [ALXN]. AAT is engaged in discovering and developing a portfolio of antibody therapeutics targeting se...

Alexion Pharmaceuticals Incorporated

Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rar...

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed ...

Alexion Pharmaceuticals, Inc. and Dicerna Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.

Fourth Quarter 2011 Financial Highlights:

More Information about "Alexion Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Alexion Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Alexion Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Alexion Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alexion Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Alexion Pharmaceuticals Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record